- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,049GBP
- Report
- September 2023
- 145 Pages
Global
From €2377EUR$2,499USD£2,024GBP
- Report
- May 2024
- 164 Pages
Global
From €5185EUR$5,450USD£4,413GBP
- Report
- January 2024
- 200 Pages
Global
From €3948EUR$4,150USD£3,361GBP
- Report
- June 2023
- 158 Pages
Global
From €2378EUR$2,500USD£2,024GBP
- Report
- September 2023
- 124 Pages
North America
From €2568EUR$2,699USD£2,186GBP
- Report
- March 2024
- 194 Pages
Global
From €3210EUR$3,374USD£2,732GBP
€3566EUR$3,749USD£3,036GBP
- Report
- October 2023
- 75 Pages
Global
From €5660EUR$5,950USD£4,818GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1903EUR$2,000USD£1,620GBP
- Report
- October 2023
- 186 Pages
Global
From €5232EUR$5,500USD£4,454GBP
- Report
- March 2024
- 181 Pages
Global
From €3210EUR$3,374USD£2,732GBP
€3566EUR$3,749USD£3,036GBP
- Report
- March 2024
- 186 Pages
Global
From €3210EUR$3,374USD£2,732GBP
€3566EUR$3,749USD£3,036GBP
- Report
- May 2023
- 169 Pages
Global
From €2236EUR$2,350USD£1,903GBP
- Report
- March 2024
- 195 Pages
Global
From €3210EUR$3,374USD£2,732GBP
€3566EUR$3,749USD£3,036GBP
- Report
- May 2024
- 134 Pages
Global
From €6183EUR$6,499USD£5,263GBP
- Report
- January 2024
- 150 Pages
Global
From €4614EUR$4,850USD£3,927GBP
- Report
- October 2023
- 185 Pages
Global
From €4661EUR$4,900USD£3,968GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1903EUR$2,000USD£1,620GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1903EUR$2,000USD£1,620GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1427EUR$1,500USD£1,215GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more